Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorWalma, M. S.
dc.contributor.authorRombouts, S. J.
dc.contributor.authorBrada, L. J. H.
dc.contributor.authorBorel Rinkes, I. H.
dc.contributor.authorBosscha, K.
dc.contributor.authorBruijnen, R. C.
dc.contributor.authorPando Rau, Elizabeth
dc.date.accessioned2021-12-28T10:23:02Z
dc.date.available2021-12-28T10:23:02Z
dc.date.issued2021-04-29
dc.identifier.citationWalma MS, Rombouts SJ, Brada LJH, Borel Rinkes IH, Bosscha K, Bruijnen RC, et al. Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trial. Trials. 2021 Apr 29;22:313.
dc.identifier.issn1745-6215
dc.identifier.urihttps://hdl.handle.net/11351/6750
dc.descriptionQuimioteràpia; Càncer de pàncrees localment avançat; Ablació per radiofreqüència
dc.description.sponsorshipOlympus Netherlands BV supported the investigator-initiated PELICAN trial with material support by providing the RFA generators and electrodes for the study. They did not have and will not have any influence on the trial design, data collection, interpretation of the data, manuscript development, or decision to publish. Furthermore, the study protocol has undergone full external peer review and received a data management and monitoring grant from the Dutch Cancer Society (grant number 2014-7244).
dc.language.isoeng
dc.publisherBMC
dc.relation.ispartofseriesTrials;22
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectPàncrees - Càncer - Tractament
dc.subjectExtirpació (Cirurgia)
dc.subjectQuimioteràpia
dc.subject.meshRadiofrequency Ablation
dc.subject.meshPancreatic Neoplasms
dc.subject.mesh/therapy
dc.subject.meshAntineoplastic Combined Chemotherapy Protocols
dc.titleRadiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trial
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1186/s13063-021-05248-y
dc.subject.decsablación por radiofrecuencia
dc.subject.decsneoplasias pancreáticas
dc.subject.decs/terapia
dc.subject.decsprotocolos de quimioterapia antineoplásica combinada
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Walma MS, Rombouts SJ, Brada LJH] Departments of Surgery, Radiology and Medical Oncology, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. Departments of Surgery, Radiology and Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. [Borel Rinkes IH, Bruijnen RC] Departments of Surgery, Radiology and Medical Oncology, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. [Bosscha K] Departments of Surgery and Medical Oncology, Jeroen Bosch Hospital, ‘s-Hertogenbosch, The Netherlands. [Pando E] Servei de Cirurgia Hepatobiliopancreàtica i Trasplantaments, Vall d’Hebron Hospital Universitari, Barcelona, Spain
dc.identifier.pmid33926539
dc.identifier.wos000654876700002
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple